Impax, Actavis, Zydus face US antitrust claims over Parkinson's treatment
MLex Summary: Impax Laboratories, Actavis Pharma and Zydus Pharmaceuticals have been accused in a US complaint of conspiring to suppress price competition for Impax's brand drug Rytary, a combination of carbidopa...To view the full article, register now.
Already a subscriber? Click here to view full article